Mycobacterium setense infection in humans

Emerging Infectious Diseases

Volumn 14, Issue 8, 2008, Pages 1330-1332

  Toro, Alexandre ^a   Adekambi, Toidi ^b   Cheynet, François ^c   Fournier, Pierre Edouard ^a   Drancourt, Michel ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; DNA 16S; ERYTHROMYCIN; HEAT SHOCK PROTEIN 65; IMIPENEM; RIFAMPICIN;

AGED; ANAMNESIS; ANTIBIOTIC SENSITIVITY; BONE BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LETTER; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM; MYCOBACTERIUM SETENSE; NUCLEOTIDE SEQUENCE; PHYLOGENY;

EID: 48749112911     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1408.080179     Document Type: Letter

References (9)

1. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 16S ribosomal DNA amplification for phylogenetic study. J Bacteriol. 1991;173:697-703.
2. Ringuet H, Akoua-Koffi C, Honore S, Varnerot A, Vincent V, Berche P, et al. hsp65 sequencing for identification of rapidly growing mycobacteria. J Clin Microbiol. 1999;37:852-7.
3. Adekambi T, Colson P, Drancourt M. rpoB-based identification of nonpigmented and late-pigmenting rapidly growing mycobacteria. J Clin Microbiol. 2003;41:5699-708. DOI: 10.1128/JCM.41.12.5699-5708.2003
4. National Committee for Clinical Laboratory Standards. Susceptibility testing of mycobacteria, Nocardiae and other aerobic actinomycetes: approved standard M24-A. Wayne (PA): The Committee; 2003.
5. Lamy B, Marchandin H, Hamitouche K, Laurent F. Mycobacterium setense sp. nov., a Mycobacterium fortuitum-group organism isolated from a patient with soft tissue infection and osteitis. Int J Syst Evol Microbiol. 2008;58:486-90. DOI: 10.1099/ijs.0.65222-0
6. Adekambi T, Stein A, Carvajal J, Raoult D, Drancourt M. Description of Mycobacterium conceptionense sp. nov., a Mycobacterium fortuitum group organism isolated from a posttraumatic osteitis inflammation. J Clin Microbiol. 2006;44:1268-73. DOI: 10.1128/JCM.44.4.1268-1273.2006
7. Wallace RJ Jr, Brown-Elliott BA, Wilson RW, Mann L, Hall L, Zhang Y, et al. Clinical and laboratory features of Mycobacterium porcinum. J Clin Microbiol. 2004;42:5689-97. DOI: 10.1128/ JCM.42.12.5689-5697.2004
8. Tejan-Sie SA, Robin K, Avery SH, Mossad SB. Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient. Scand J Infect Dis. 2000;32:94-6. DOI: 10.1080/00365540050164317
9. Lee SM, Kim J, Jeong J, Park YK, Bai GH, Lee EY, et al. Evaluation of the broth microdilution method using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing. J Korean Med Sci. 2007;22:784-90.